The Washington Post’s story “Eli Lilly ramps up its fight against imitation weight-loss drugs”...
In a piece on the battle between Eli Lilly and compounding pharmacists over tirzepatide — notably the lawsuit by the Outsourcing Facilities Association — Quartz magazine referenced APC’s statement telling 503A members to “immediately cease preparing and dispensing compounded copies of Mounjaro and Zepbound.”
The Washington Post’s story “Eli Lilly ramps up its fight against imitation weight-loss drugs”...
NPR ran an updated story on the ‘battle’ between compounders and drug makers over GLP-1 weight-loss...
Inside Health Policy used APC for information in its piece “Uncertainty Looms Over Bulk Production...